Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhouyi Wu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Science Bulletin|January 19, 2023
Demonstration of topological wireless power transferLi Zhang, Yihao Yang, Zhao Jiang, et al.
Antibody Therapeutics|September 8, 2023
Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305Zhouyi Wu, Gangling Xu, Wu He, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Erratum: Author correction to "Up-regulation of glyclipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication" [Acta Pharm Sin B 9 (2019) 769-781]Menghao Huang, Hu Li, Rong Xue, et al.
Acta Pharmaceutica Sinica. B|January 30, 2020
Erratum: Author correction to 'Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication' [Acta Pharmaceutica Sinica B 9 (2019) 769-781]Meng-Hao Huang, Hu Li, Rong Xue, et al.
Acta Pharmaceutica Sinica. B|August 7, 2019
Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replicationMeng-Hao Huang, Hu Li, Rong Xue, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Science Bulletin|January 19, 2023
Demonstration of topological wireless power transferLi Zhang, Yihao Yang, Zhao Jiang, et al.
Antibody Therapeutics|September 8, 2023
Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305Zhouyi Wu, Gangling Xu, Wu He, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Erratum: Author correction to "Up-regulation of glyclipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication" [Acta Pharm Sin B 9 (2019) 769-781]Menghao Huang, Hu Li, Rong Xue, et al.
Acta Pharmaceutica Sinica. B|January 30, 2020
Erratum: Author correction to 'Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication' [Acta Pharmaceutica Sinica B 9 (2019) 769-781]Meng-Hao Huang, Hu Li, Rong Xue, et al.
Acta Pharmaceutica Sinica. B|August 7, 2019
Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replicationMeng-Hao Huang, Hu Li, Rong Xue, et al.
Pageof 2